Found 13 matching trials
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
PHASE1The study is an open-label pilot study in newly diagnosed glioblastoma pati...
Location
University of California San Francisco
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
PHASE1Tumor Treating Fields targeted to liver metastases may improve outcomes for...
Location
HonorHealth Research Institute
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
PHASE1The purpose of this study is to determine the safety and efficacy of the co...
Location
Stanford University
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
PHASE2Glioblastoma multiforme (GBM) is the most common and deadliest primary mali...
Location
University of Florida
Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PHASE1This study is for newly diagnosed WHO Grade IV malignant glioma patients to...
Location
University of California San Diego Medical Center
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
NAThe purpose of this study is to find out what effects, good or bad, the Opt...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
N/AThe purpose of this prospective, nonrandomized controlled phase IV study is...
Status
Active Not Recruiting
Location
Froedtert Hospital & Medical College of Wisconsin
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
PHASE3The study is a prospective, randomly controlled pivotal trial, designed to ...
Location
University of Alabama at Birmingham
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
PHASE2This is a prospective, open-label, single arm, historical control pilot stu...
Location
Nemocnice Na Homolce
Niraparib/TTFields in GBM
PHASE2Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania